Literature DB >> 26455359

Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort study.

Kika Anyiwe1, Yao Qiao1, Prithwish De1,2, Eric M Yoshida3, Craig C Earle4,5, Hla-Hla Thein1,4,5.   

Abstract

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) incidence is increasing worldwide and cirrhosis is the most important risk factor predominantly caused by chronic viral hepatitis infection. We studied the impact of socioeconomic status (SES) on HCC incidence and stage at diagnosis among viral hepatitis cases.
METHODS: A population-based retrospective cohort study was conducted through the Ontario Cancer Registry linked data. Incidence rates were calculated using person-time methodology. Association between SES (income quintile) and HCC incidence was assessed using proportional-hazards regression. The impact of SES on HCC stage was investigated using logistic regression.
RESULTS: Among 11 350 individuals diagnosed with viral hepatitis between 1991 and 2010, a crude HCC incidence rate of 21.4 cases per 1000 person-years was observed. Adjusting for age, gender, urban/rural residence and year of viral hepatitis diagnosis, a significant association was found between SES and HCC incidence, with an increased risk among individuals in the lowest three income quintiles (incidence rate ratio, IRR = 1.235; 95% CI: 1.074-1.420; IRR = 1.183; 95% CI: 1.026-1.364; IRR = 1.158; 95% CI: 1.000-1.340 respectively). No significant association between SES and HCC incidence was found after additionally adjusting for risk factors associated with HCC. However, HCC risk factors such as cirrhosis and HIV are associated with SES. Furthermore, no association was found between SES and HCC stage.
CONCLUSIONS: The association between SES and HCC incidence is likely because of differences in risk factors across income quintiles. Investigating how SES affects HCC incidence facilitates an understanding of which populations are at elevated risk for HCC.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer staging; liver cancer; medical record linkage; socioeconomic status; viral hepatitis

Mesh:

Year:  2015        PMID: 26455359     DOI: 10.1111/liv.12982

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

1.  Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma.

Authors:  Alessandro Paro; Djhenne Dalmacy; Diamantis I Tslimigras; Jordan Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2022-04-19       Impact factor: 5.344

2.  Socioeconomic Status in Relation to Risks of Major Gastrointestinal Cancers in Chinese Adults: A Prospective Study of 0.5 Million People.

Authors:  Yuanjie Pang; Christiana Kartsonaki; Yu Guo; Yiping Chen; Ling Yang; Zheng Bian; Fiona Bragg; Iona Y Millwood; Jun Lv; Canqing Yu; Junshi Chen; Liming Li; Michael V Holmes; Zhengming Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-27       Impact factor: 4.254

Review 3.  An Ecological Evaluation of Vinyl Chloride Exposure and Liver Cancer Incidence and Mortality in Texas.

Authors:  Kevin M Towle; Stacey M Benson; Natalie S Egnot; Gary M Marsh
Journal:  J Clin Transl Hepatol       Date:  2020-12-30

4.  Association between socioeconomic status and survival in patients with hepatocellular carcinoma.

Authors:  Yongshun Zheng; Xun Zhang; Jinsen Lu; Shuchen Liu; Yeben Qian
Journal:  Cancer Med       Date:  2021-08-20       Impact factor: 4.452

5.  Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.

Authors:  Robert J Wong; Sammy Saab; Peter Konyn; Vinay Sundaram; Mandana Khalili
Journal:  Am J Gastroenterol       Date:  2021-02-01       Impact factor: 12.045

6.  Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.

Authors:  Hla-Hla Thein; Kika Anyiwe; Nathaniel Jembere; Brian Yu; Prithwish De; Craig C Earle
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

7.  Risk factors for developing liver cancer in people with and without liver disease.

Authors:  Jae Kyung Suh; Jayoun Lee; Jeong-Hoon Lee; Sangjin Shin; Ha Jin Tchoe; Jin-Won Kwon
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.